Tatva Chintan Pharma Chem Limited - Company Profile

It is a chemicals and materials public limited company based in Ankleshwar, Gujarat, India, established in 1996.
1996 Ankleshwar, Gujarat, India Active
Last Updated:
About Tatva Chintan Pharma Chem Limited

Tatva Chintan Pharma Chem Limited, a active public limited company, was established on 12 June 1996 in Ankleshwar, Gujarat, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: L24232GJ1996PLC029894. Registered under ROC Roc Ahmedabad. it is listed on BSE: 543321 and NSE: TATVA. It has an authorized capital of ₹40.00 Cr and a paid-up capital of ₹23.39 Cr.

Formerly known as Tatva Chintan Pharma Chem Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹386.19 Cr and a net worth of ₹725.88 Cr. Employing 705 professional, Its leadership includes Avani Rajesh Umatt (Director), Manher Chimanlal Desai (Director), Subhash Ambubhai Patel (Director). Past directors included Ashok Bothra, Apurva Vijaykumar Dubey, Sudip Sanat Ray. It holds ₹384.05 Cr open charges and ₹63.80 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 502/17 Gidc Estate Ankleshwar Gidc, Ankleshwar, Gujarat, 393002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24232GJ1996PLC029894

  • Registration Number

    029894

  • Incorporation Date

    12 June 1996

  • Authorized Capital

    ₹40.00 Cr

  • Paid-Up Capital

    ₹23.39 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 543321, NSE: TATVA)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 23.39 Cr
  • Company Age 29 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 384.05 Cr
  • Satisfied Charges ₹ 63.80 Cr
  • Revenue Growth **** -5.51%
  • Profit Growth **** -27.47%
  • Ebitda **** 22.29%
  • Net Worth 43.80%
  • Total Assets **** 7.98%
Company report

Tatva Chintan Pharma Chem Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Tatva Chintan Pharma Chem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Tatva Chintan Pharma Chem Limited?
Current Directors
Name Designation Appointment Date Status
Avani Rajesh Umatt Director 27 Feb 2021 Current
Manher Chimanlal Desai Director 27 Feb 2021 Current
Subhash Ambubhai Patel Director 27 Feb 2021 Current
Ajaykumar Mansukhlal Patel Whole-Time Director 12 Jun 1996 Current
Shekhar Rasiklal Somani Whole-Time Director 12 Jun 1996 Current
Chintan Nitinkumar Shah Managing Director 12 Jun 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Cfo 30 Aug 2025 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Cfo(Kmp) 25 Feb 2019 Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tatva Chintan Pharma Chem.

Tatva Chintan Pharma Chem Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 5.51% decrease. The company also saw a substantial fall in profitability, with a 27.47% decrease in profit. The company's net worth Soared by an impressive increase of 43.8%.

Tatva Chintan Pharma Chem revenue growth over time
Tatva Chintan Pharma Chem profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-5.51%
*******
*******
*******
*******
Revenue from Operations
*******
-6.05%
*******
*******
*******
*******
Total Assets
*******
7.98%
*******
*******
*******
*******
Profit or Loss
*******
-27.47%
*******
*******
*******
*******
Net Worth
*******
43.80%
*******
*******
*******
*******
EBITDA
*******
22.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tatva Chintan Pharma Chem?

In 2024, Tatva Chintan Pharma Chem had a promoter holding of 72.02% and a public holding of 27.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,840,500,000.00

Satisfied Charges

₹638,031,000.00

Charges Breakdown by Lending Institutions
  • Others : 224.25 Cr
  • Citi Bank N.A. : 111.50 Cr
  • State Bank Of India : 45.00 Cr
  • Axis Bank Limited : 3.30 Cr
Latest Charge Details
Date Lender Amount Status
24 Aug 2022 State Bank Of India ₹45.00 Cr Open
14 Jun 2022 Others ₹35.00 Cr Open
01 Jan 2021 Axis Bank Limited ₹1.10 Cr Open
31 Dec 2020 Axis Bank Limited ₹1.10 Cr Open
31 Dec 2020 Axis Bank Limited ₹1.10 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Tatva Chintan Pharma Chem?

Tatva Chintan Pharma Chem has a workforce of 705 employees as of Sep 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tatva Chintan Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tatva Chintan Pharma Chem's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tatva Chintan Pharma Chem
Recent Activity within the Organization
  • Director Appointment

    The activity Ajesh Kumar Pillai was appointed as a Cfo was appointed as a Cfo on 28 Nov 2025 & has been associated with this company since 3 months 10 days . was completed.

  • Annual General Meeting

    Progress on Tatva Chintan Pharma Chem Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge registered on 21 Nov 2019 via Charge ID 100308707 with Citi Bank N.A. was fully satisfied on 05 Jun 2025. was completed.

  • Balance Sheet

    Tatva Chintan Pharma Chem Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    The activity A charge with Citi Bank N.A. of Rs. 85.00 Cr registered on 17 Jan 2017 with Charge ID 100115057 was modified on 09 Jan 2024. was completed.

  • Charges

    Progress on A charge with Others of Rs. 65.50 Cr registered on 14 Oct 2014 with Charge ID 10533636 was modified on 21 Nov 2023. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Tatva Chintan Pharma Chem Limited?

The CIN of Tatva Chintan Pharma Chem Limited is L24232GJ1996PLC029894.

Where is Tatva Chintan Pharma Chem Limited headquartered?

Tatva Chintan Pharma Chem Limited is headquartered at Plot No 502/17 Gidc Estate Ankleshwar Gidc, Ankleshwar, Gujarat, 393002.

When was Tatva Chintan Pharma Chem Limited incorporated?

Tatva Chintan Pharma Chem Limited was incorporated on 12 June 1996.

Who are the current directors of Tatva Chintan Pharma Chem Limited?

The current directors of Tatva Chintan Pharma Chem Limited are

What is the primary industry of Tatva Chintan Pharma Chem Limited?

The primary industry of Tatva Chintan Pharma Chem Limited is Manufacturing.

Is Tatva Chintan Pharma Chem Limited a listed company?

Tatva Chintan Pharma Chem Limited is listed. It is listed on BSE: 543321 and NSE: TATVA.

What is the capital structure of Tatva Chintan Pharma Chem Limited?

The authorized capital of Tatva Chintan Pharma Chem Limited is ₹40.00 Cr, and the paid-up capital is ₹23.39 Cr.

What is the compliance status of Tatva Chintan Pharma Chem Limited?

The compliance status of Tatva Chintan Pharma Chem Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available